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The colonic mucus layer is a dynamic and complex structure formed by secreted
and transmembrane mucins, which are high-molecular-weight and heavily glycosylated
proteins. Colonic mucus consists of a loose outer layer and a dense epithelium-attached
layer. The outer layer is inhabited by various representatives of the human gut microbiota
(HGM). Glycans of the colonic mucus can be used by the HGM as a source of carbon
and energy when dietary fibers are not sufficiently available. Both commensals and
pathogens can utilize mucin glycans. Commensals are mostly involved in the cleavage
of glycans, while pathogens mostly utilize monosaccharides released by commensals.
This HGM-derived degradation of the mucus layer increases pathogen susceptibility
and causes many other health disorders. Here, we analyzed 397 individual HGM
genomes to identify pathways for the cleavage of host-synthetized mucin glycans to
monosaccharides as well as for the catabolism of the derived monosaccharides. Our
key results are as follows: (i) Genes for the cleavage of mucin glycans were found in
86% of the analyzed genomes, which significantly higher than a previous estimation.
(ii) Genes for the catabolism of derived monosaccharides were found in 89% of the
analyzed genomes. (iii) Comparative genomic analysis identified four alternative forms of
themonosaccharide-catabolizing enzymes and four alternative forms of monosaccharide
transporters. (iv) Eighty-five percent of the analyzed genomesmay be involved in potential
feeding pathways for the monosaccharides derived from cleaved mucin glycans. (v) The
analyzed genomes demonstrated different abilities to degrade known mucin glycans.
Generally, the ability to degrade at least one type of mucin glycan was predicted for 81%
of the analyzed genomes. (vi) Eighty-two percent of the analyzed genomes can form
mutualistic pairs that are able to degrade mucin glycans and are not degradable by any
of the paired organisms alone. Taken together, these findings provide further insight into
the inter-microbial communications of the HGM as well as into host-HGM interactions.
Keywords: human gut microbiome, comparative genomics, mucin glycans, carbohydrate utilization, metabolism
reconstruction
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INTRODUCTION
The colonic mucus layer is a dynamic and complex structure
that is mainly composed of the glycoprotein mucin-2 (MUC2)
(Johansson et al., 2008). MUC2 is characterized by abundant
glycosylation. Highly variable glycan structures are O-linked to
serine or threonine residues that are concentrated in so-called
PTS (proline, threonine, and serine) domains. The mass of the
glycosylated MUC2 protein is approximately 2.5 MDa, and more
than 80% of this mass comes from carbohydrates (Lang et al.,
2007). Glycosylated MUC2 can form a gel-like structure due
to its N- and C-terminal domains that form numerous cross-
links between cysteine residues (Johansson et al., 2013). Due to
these cross-links, MUC2 forms a mucus structure. The colonic
mucus consists of two layers, a loose outer layer and a dense
epithelium-attached layer (Johansson et al., 2011). The inner
layer acts as a physical barrier preventing bacteria from accessing
the epithelium, whereas the outer layer is densely populated by
various commensal microbes (Johansson et al., 2011, 2015; Li
et al., 2015).
Interactions between the human gut microbiota (HGM) and
colonic mucus are not limited just to residing of the microbes in
the outer layer mucus. Thus, once in the outer mucus layer, gut
microbes not only avoid washout by the contents flowing through
the colon but also are able to access mucin glycans that can be
used as sources of carbon and energy. Usually HGM microbes
switch to mucin glycans in a shortage of dietary fibers, because
multiple intestinal microbes can switch between dietary and host
glycans (Mahowald et al., 2009). Both commensal and pathogenic
microbes are able to degrade mucin glycans. The commensal
microbes are usually able to cleave glycans with secreted
glycosyl hydrolases (GHs) and lyases and further catabolize the
derived monosaccharides, whereas most intestinal pathogens
use monosaccharides released by commensal-secreted enzymes
(Martens et al., 2008; Koropatkin et al., 2012; Marcobal et al.,
2013; Cameron and Sperandio, 2015; Pacheco and Sperandio,
2015). Being both an environmental niche and a food source, the
mucus layer plays a key role in shaping the HGM composition
(Koropatkin et al., 2012; Johansson et al., 2015). In turn, the
HGM is able to modulate mucus chemical composition via the
degradation of glycans and peptides and the local release of
bioactive factors that can change the expression patterns of the
mucin-producing host cells (Deplancke and Gaskins, 2001). The
degradation of mucin glycans is highly dependent on the host
diet. Thus, decreased levels of fibers in the diet force the HGM
to degrade more mucin glycans, resulting in the thinning and
depletion of the mucus layer, which subsequently enhances host
susceptibility to pathogens (Marcobal et al., 2013; Tailford et al.,
2015; Desai et al., 2016). Additionally, depletion of the colonic
mucus is associated with such disorders as Crohn’s disease, celiac
disease, colonic ischemia, compound exocytosis, and ulcerative
colitis (Png et al., 2010; Joossens et al., 2011; Parmar et al., 2012;
Johansson et al., 2013; Arike and Hansson, 2016; Cockburn and
Koropatkin, 2016).
Because of the significant mucus-microbiota interaction,
multiple HGM organisms have been analyzed for their
abilities to degrade mucin glycans. To date, more than
50 mucus-degrading bacterial strains, generally belonging
to Akkermansia muciniphila, Bacteroides spp., Barnesiella
intestinihominis, Bifidobacterium spp., Eubacterium spp., and
Ruminococcus spp. (Derrien et al., 2004; Sonnenburg et al., 2005;
Martens et al., 2008; Comstock, 2009; Png et al., 2010; Kiyohara
et al., 2012; Pudlo et al., 2015; Tailford et al., 2015; Desai et al.,
2016), have been identified.
In this study, we analyzed the degradation of mucin glycans by
the HGM using comparative genomic analysis. The comparative
genomic analysis of sugar utilization by microbes is a recent
but actively developing research area. A comparative genomic
approach, combining a phylogenomics and genome-context
based techniques (Osterman and Overbeek, 2003; Rodionov,
2007), has been previously applied for the analysis of sugar
utilization in various microbial taxa, including multiple HGM
strains (Leyn et al., 2012; Ravcheev et al., 2013; Zhang et al.,
2015; Khoroshkin et al., 2016). Here, we used this comparative
approach not to a set of related organisms, but tomicroorganisms
cohabiting a certain environment, being the human intestine.
Unlike functional analysis of metagenomes, this analysis is
based on a reconstruction of metabolic pathways in individual
genomes of microbes found in the studied environmental
community and further prediction of possible interactions
between different microorganisms. This approach has not
previously been used for the detailed analysis of sugar utilization
but it has been repeatedly used to reconstruct other metabolic
pathways, including respiration (Ravcheev and Thiele, 2014),
biosynthesis of B-vitamins (Magnúsdóttir et al., 2015), and
quinones (Ravcheev and Thiele, 2016), as well central carbon
metabolism and biosynthesis of amino acids and nucleotides
(Magnúsdóttir et al., 2017), in multiple HGM genomes.
Here, we used a comparative genomics approach to analyze
the degradation of mucin glycans as well utilization of the
derived monosaccharides as carbon and energy sources in HGM
genomes. Additionally, we predicted potential feeding pathways
for mucin glycan-derived monosaccharides, the specificity of
various HGM strains for different types of mucin glycans, and
mutualistic relationships for the cleavage of mucin glycans by
different HGM organisms.
MATERIALS AND METHODS
Analyzed Genomes
The analyzed genomes were selected using the following steps.
(1) All genomes listed in the Human Microbiome Project (HMP,
http://www.hmpdacc.org/HMRGD/) as of 17.09.2015 and 459
genomes with the body site “Gastrointestinal tract” (i.e., isolated
from the intestine) were selected. (2) All the genomes absent
from the PubSEED (Overbeek et al., 2005; Disz et al., 2010)
and Integrated Microbial Genomes (IMG) databases (Markowitz
et al., 2014) were excluded. Among the remaining 397 genomes,
71 had a finished sequencing status whereas 326 others had a
draft status (Table S1). These genomes represent 288 microbial
species, 89 genera, 45 families, 19 orders, 14 classes, and 8
phyla. All the selected genomes, except 2 Archaea, are bacterial.
The phyletic distribution of the analyzed genomes is in good
agreement with that observed in various HGM (Eckburg et al.,
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2005; Goodman et al., 2011; Walker et al., 2011; Graf et al.,
2015). Thus, the most represented phyla are Actinobacteria
(37 genomes, 9.3% of the analyzed genomes), Bacteroidetes
(69 genomes, 17.3%), Firmicutes (197 genomes, 49.6%), and
Proteobacteria (71 genomes, 17.9%).
Approach, Tools, and Databases
The PubSEED platform was used to annotate the genes
responsible for the degradation of mucin glycans using
the following comparative genomics approach. To avoid
misannotation, all of the proteins with the same function were
checked for orthology. Orthologs were defined as the best
bidirectional hits that have a similar genomic context. To search
for the best bidirectional hits, a BLAST algorithm (Altschul et al.,
1997) implemented in PubSEED and the IMG platform was
used with the following parameters, a score ≥150 bits, an e-
value ≤ e−50, a protein identity and positives ≥25 and ≥40%,
respectively, a query coverage at least 70%. To analyze genomic
context, we used PubSEED and STRING v9.1 (Franceschini
et al., 2013) along with phylogenetic trees for protein domains
in MicrobesOnline (Dehal et al., 2010). To analyze protein
domain structure, we searched the Pfam (Finn et al., 2014)
and CDD (Marchler-Bauer et al., 2013) databases and the
“Domains & Families” option of the MicrobesOnline platform
with the threshold e−30. Additionally, functional annotations of
the analyzed genes were performed using the UniProt (Magrane
and Consortium, 2011), KEGG (Kanehisa et al., 2012), and
MetaCyc (Caspi et al., 2014) databases.
After annotation of orthologs for the known analyzed genes,
all the catabolic pathways (CPs) for monosaccharides utilization
were checked for gaps. The CP was defined as sequence of
reactions from intracellular monosaccharide to the intermediate
of the central carbohydrate metabolism (glycolytic pathways
or TCA cycle). A gap was defined as an absence of enzyme-
encoding genes responsible for one or more reactions. Length
of the gap was defined as a number of successive reactions
corresponding to the absent genes. A CP was considered to be
present in the organism if no more than two gaps were found
and length of each gap was maximally one reaction. A search
of the non-orthologous displacement was done for the gaps in
the present pathways as well as for transporters absent in the
presence of CP. If non-orthologous replacement was predicted,
its orthologs were searched in all analyzed genomes. Afterwards,
CPs were checked for gaps again while considering the identified
non-orthologous replacements and the presence of CPs was
re-evaluated.
To search for the protein homologs, a BLAST algorithm
implemented in the PubSEED and the IMG platforms was
used, with the following parameters, an e-value ≤ e−20,
a protein identity ≥20%. Multiple protein alignments
were performed using the MUSCLE v. 3.8.31 tool (Edgar,
2004a,b). Phylogenetic trees were constructed using the
maximum-likelihood method with the default parameters
implemented in PhyML-3.0 (Guindon et al., 2010). The
obtained trees were visualized and midpoint-rooted
using the interactive viewer Dendroscope, version 3.2.10,
build 19 (Huson et al., 2007). To clarify the taxonomic
affiliations of the analyzed genomes, the NCBI Taxonomy
database (http://www.ncbi.nlm.nih.gov/taxonomy) was
used. Analysis of gene occurrence was performed using the
“Phylogenetic Profiler for Single Genes” option of the IMG
platform.
The non-random distribution of the analyzed pathways, was
tested using the Chi-squared test of observed frequencies of
combinations with R (version 3.2.3).
All of the annotated genes are represented as a subsystem
in PubSEED (http://pubseed.theseed.org/SubsysEditor.cgi;
subsystem names are “Galactose utilization HGM,” “L-
fucose utilization HGM,” “N-Acetylgalactosamine utilization
HGM,” “N-Acetylglucosamine utilization HGM,” and “N-
Acetylneuraminic acid utilization HGM”) and in Tables S2–S7.
The protein sequences for the annotated genes in FASTA format
are represented in the file Sequences S1 in the Supplementary
Materials.
Genome-Context and Phylogenomic
Approaches for Functional Annotation
The functions of some genes cannot be correctly annotated based
on sequence similarity alone. Thus, a search of orthologs as
described in Approach, Tools, and Databases is often incorrectly
applied to large protein families containing proteins with
different functions (Rodionov, 2007; Promponas et al., 2015).
Additionally, the existence of non-orthologous displacements
(Galperin and Koonin, 1998) require advanced approaches as
genome context-based methods. Below, we describe non-trivial
methods used in this work for functional annotation of the
analyzed genes.
Annotation of the fucK and fucA Genes
The main cause of misannotation for the fuc genes is their
similarity to the genes for rhamnose utilization. Both the
FucK and RhaB proteins belong to the FGGY family of
carbohydrate kinases (Pfam: PF02782), whereas the FucA
and RhaD proteins belong to the Aldolase_II family (Pfam:
PF00596). We used the following steps to distinguish fuc and
rha genes. (1) The fucI gene was used as a signature gene
for the Fuc utilization pathway because this gene has no
homologs among rhamnose-catabolizing enzymes. Orthologs
for the FucI were found as described in Approach, Tools,
and Databases. FucI proteins marked as reviewed in UniProt
database were used as a query. Then, domain structures of all
identified orthologs were analyzed and all the FucI orthologs
demonstrated the presence of L-fucose isomerase domain (Pfam:
PF07882) with e-value < e−110. The domain structure was used
as an additional confirmation of orthology. (2) Phylogenetic
maximum-likelihood trees were built for the FucK/RhaB-
(Figure S1) and FucA/RhaD-like proteins (Figure S2) found in
the analyzed genomes. (3) Genes that chromosomally clustered
with fucI were annotated as fucK and fucA. (4) Single-copy
genes found in genomes having fucI but lacking any rha
genes were annotated as fucK and fucA. (5) The remaining
non-annotated genes were annotated by their positions on
the phylogenetic trees relative to the previously annotated
genes.
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Prediction of Non-orthologs Replacements for the Fcl
Fucose Catabolism Pathway
Non-orthologous displacements for genes for the Fcl pathways
were found by an analysis of the chromosomal clusters
in genomes having fclBC gene clusters but lacking the
fclA, fclD, and fclE genes. The six genomes satisfying these
criteria, were analyzed, Bifidobacterium bifidum NCIMB
41171, Bifidobacterium breve DSM 20213, Bifidobacterium
breve HPH0326, Bifidobacterium longum ATCC 15697,
Bifidobacterium pseudocatenulatum DSM 20438, and
Corynebacterium ammoniagenes DSM 20306. Genes found
to be chromosomally clustered with the fclBC were proposed to
be non-orthologous replacements for the fclADE genes and their
possible functions were predicted as described below.
The non-orthologs displacement for fclE, was predicted
by similarity of the encoded protein to 4-hydroxy-
tetrahydrodipicolinate synthase (DHDPS family, Pfam:
PF00701). Because pyruvate is a product of FclE-catalyzed
reaction (Yew et al., 2006) as well of reactions catalyzed by
enzymes from DHDPS family (N-acetylneuraminate lyase and
trans-o-hydroxybenzylidenepyruvate hydratase-aldolase), we
concluded that the analyzed protein is an alternative form of
FclE and named it FclE2.
The non-orthologous displacement for FclA and FclD
proteins was predicted by analysis of protein families and
phylogenetic trees. Thus, the fclBC-clustered gene was found
to belong to the short-chain dehydrogenase family (Pfam:
PF00106). Because this family includes experimentally analyzed
FucA and FucD proteins from and Burkholderia multivorans
(Hobbs et al., 2013), we constructed phylogenetic trees for FclA
and FclD proteins as well short-chain dehydrogenase family
proteins encoded in the fclBC chromosomal clusters (Figure
S3). Because all the fclBC-clustered proteins formed a branch,
separated from both FclD and FclA branches, we proposed that
they have two functions, thus being non-orthologs replacements
for both FclD and FclA. These proteins were were designated
FclA2/FclD2.
Prediction of Novel Fucose-Specific ABC Transport
System
Possible Fuc-specific ABC transport systems have been predicted
by chromosomal clustering with the fuc genes in 25 analyzed
genomes, including Actinomyces spp., Clostridium spp.,
Coprococcus spp., Lachnospiraceae bacterium, Ruminococcus
spp., and Enterobacter spp. The closest experimentally analyzed
homolog of the substrate-binding subunit of this system is the
substrate-binding protein AraF of the arabinose-specific ABC
system from E. coli (Johnson and Schleif, 2000). Additionally,
genes of this system co-cluster together with the fcl genes in the
genomes of Streptomyces sp. HGB0020, Bifidobacterium longum
ATCC 15697, and Bifidobacterium pseudocatenulatum DSM
20438.
Annotation of Homologous Enzymes for GalNAc and
GlcNAc Metabolism
Previously it was found that at least some Firmicutes and
Proteobacteria can utilize only galactosamine (GalN) but
not GalNAc (Leyn et al., 2012; Zhang et al., 2015). The
crucial feature of the GalNAc-utilizing microorganisms is
the presence of the agaA gene for N-acetylgalactosamine-
6-phosphate deacetylase. For proper pathway reconstruction,
AgaA should be distinguished from the N-acetylglucosamine-
6-phosphate deacetylase NagA, which is involved in GlcNAc
utilization. For this purpose, we used the following pipeline. (1)
The agaS and gene was selected as signature gene for the GalNAc
utilization pathway, and nagBwas used as a signature gene for the
GlcNAc utilization pathway. These genes were selected because
AgaS have no homologs in the GlcNAc utilization pathway
and NagB has no homologs in GalNAc utilization pathway.
(2) Orthologs for AgaS were found as described in Approach,
Tools, and Databases. For a query, proteins marked as reviewed
in UniProt database as well AgaS proteins annotated at the
RegPrecise database (Novichkov et al., 2013) were used. The
domain structures of all found AgaS orthologs were analyzed and
all them demonstrated the presence of SIS_AgaS_like domain
(NCBI CDD: cd05010) with e-value < e−70. Additionally, the
phylogenetic maximum-likelihood tree for the AgaS proteins
was constructed (Figure S4). The constructed tree was quite
compact, did not include long branches, and its structure was
in agreement with microbial taxonomy, which was used as an
additional corroboration for orthology of all the predicted AgaS
proteins. (3) Orthologs for the NagB were found as described in
Approach, Tools, and Databases. For a query, proteins marked
as reviewed in UniProt database as well AgaS proteins annotated
at the RegPrecise database were used. All these orthologs belong
to the GlcN6P_deaminase family (NCBI CDD: cd01399) with an
e-value < e−100. (4) A phylogenetic maximum-likelihood tree
was built for AgaA/NagA-like proteins (Figure S5) found in the
analyzed genomes. (5) Genes chromosomally clustered with agaS
were annotated as agaA, while genes chromosomally clustered
with nagB were annotated as nagA. (6) Genes that co-occurred
in the genomes with only agaS were annotated as agaA, and
genes that co-occurred in the genomes with only nagB were
annotated as nagA. (7) The remaining non-annotated genes were
annotated by their positions on the phylogenetic trees relative to
the previously annotated genes.
Annotation of the GalNAc-Specific Transporters
Three PTSs associated with various aga genes were previously
identified, including a GalNAc-specific (AgaPTS), a GalN-
specific (GamPTS), and a GnbPTS with multiple specificities
(Leyn et al., 2012; Bidart et al., 2014; Zhang et al., 2015).
The GnbPTS can transport and phosphorylate three different
compounds: GalNAc, lacto-N-biose (Galβ-1,3-GlcNAc), and
galacto-N-biose (Galβ-1,3-GalNAc).
Only AgaPTS and GnbPTS but not GamPTS are involved
in GalNAc catabolism. We used the following steps to
distinguish the various types of PTSs associated with aga genes.
(1) Homologs were found for all the previously annotated
EIIC components of the AgaPTS, GamPTS, and GnbPTS as
described in Approach, Tools, and Databases. EIIC components
were selected because these components are substrate-binding
subunits. Query proteins were extracted from the RegPrecise
database. (2) A phylogenetic maximal-likelihood tree was
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constructed for the EIIC components of the analyzed PTS
systems (Figure S6). (3) The EIIC components clustered with the
gnbG gene were annotated as binding GalNAc as well lacto- and
galacto-N-biose. The gnbG gene encodes intracellular glycosyl-
hydrolase, specific to lacto- and galacto-N-biose and clustered
with the GnbPTS in all genomes previously analyzed (Bidart
et al., 2014; Zhang et al., 2015). Additionally, the EIIC proteins
clustered with the GnbG are clearly separated on the phylogenetic
tree (Figure S6) and thus can be easily distinguished from their
homologs. (4) The AgaS protein was used as a signature for the
GalNAc and GalN utilization pathways, whereas the presence or
absence of AgaA protein was used as a signature for GalNAc or
GalN utilization, respectively (see Annotation of Homologous
Enzymes for GalNAc and GlcNAc Metabolism). Thus, proteins
co-clustered with the agaS and agaA genes were annotated as
GalNAc specific and corresponding PTS systems were annotated
as AgaPTS. (5) The EIIC proteins that co-clustered with the agaS
but not the agaA genes were annotated as GalN-specific and
corresponding PTS systems were annotated as GamPTS.
Prediction of a Novel GlcNAc-Specific Transporter
An alternative ABC transporter for GlcNAc was predicted in this
work and named NgcABCD. This transporter was predicted by
analysis of gene clusters. Thus, genes for putative ABC transport
system were co-clustered together with the nagKAB genes in
15 genomes of Bifidobacterium spp. The following differences
were found between the NgcABCD and the previously described
ABC-transporter NgcEFG (Xiao et al., 2002). First, the ngcEFG
operon encodes only the substrate-binding protein and two
intermembrane proteins, whereas the ngcABCD operon encodes
an additional protein, an ATP-binding protein. Second, the
substrate-binding subunits of these systems belong to different
protein families; NgcE is a member of the SBP_bac_8 family
(Pfam: PF13416), whereas NgcA is a member of the SBP_bac_5
family (Pfam: PF00496).
Prediction of a Non-orthologous Replacement for the
Uridylyltransferase GalT
To predict non-orthologous displacement of these genes, we used
an analysis of gene occurrence also known as “Phyletic patterns”
(Osterman and Overbeek, 2003; Tatusov et al., 2003). For the
prediction of the non-orthologous displacement of galT, two
sets of genomes were selected. The first set included finished
genomes having galK but not galT. The second set included
finished genomes having both galK and galT (Table S8). Finished
genomes were selected because draft genomes do not allow us
to distinguish the actual absence of the gene in the genome or
the location of the gene in an unsequenced part of the genome.
Candidate functional analogs of GalT were identified as genes
present in genomes having only galK but absent in genomes
having galKT genes. For the analysis of gene co-occurrence, we
used the “Phylogenetic Profiler for Single Genes” tool available
at the IMG JGI web-resource (https://img.jgi.doe.gov/). For
the phylogenetic profiling the algorithm “By Present/Absent
Homologs” was applied with the following parameters, maximal
e-value = 1e-10, minimal identity = 30%, minimal percentage
of taxa with homologs = 50%, and minimal percentage of taxa
without homologs= 50%.
All the found 62 candidates (Table S8) were filtered to exclude
membrane, regulatory, and secreted proteins, and then their
domain structure and chromosomal environment were analyzed.
The gene Amuc_0031 in the A. muciniphila genome (named
galY), here was considered as the best candidate because of
the following. (1) Encoded protein belongs to the nucleotidyl
transferase (NTP_transferase, Pfam: PF00483) family, members
of that are able to transform phosphosugars onto nucleotide
sugars (Jensen and Reeves, 1998). (2) Orthologs of this gene from
the analyzed genomes form a single monophyletic branch on
a phylogenetic maximum-likelihood tree (Figure S7). Analysis
of the tree together with the gene occurrence patterns showed
that all homologs found in genomes lacking galT form a
monophyletic branch. (3) Genes, encoding orthologs for this
protein, were clustered with the galE gene in 15 analyzed
genomes as wall with the galMP operon in two analyzed
genomes.
Prediction of a Novel Galactose-Specific Transporter
A new Gal-specific transporter was predicted based on co-
clustering of its gene together with galK in the genomes
of Propionibacterium spp. and with galKT in the genomes
of Streptomyces spp. This transporter is member of the SSS
family (sodium solute symporter, Pfam: PF00474). The predicted
function was checked by an analysis of chromosomal context for
the orthologs of this gene.
RESULTS
Collecting the Data on Degradation of
Mucin Glycans and Utilization of Derived
Monosaccharides
Mucin glycans are complex polysaccharides that contain five
different monosaccharides, L-fucose (Fuc), D-galactose (Gal),
N-acetyl-D-galactosamine (GalNAc), N-acetyl-D-glucosamine
(GlcNAc), and N-acetylneuraminic acid (Neu5Ac), and can form
various glycosidic bonds (Podolsky, 1985; Tailford et al., 2015).
Evidently, degradation of such complex structures requires a
large number of bacterial proteins interacting with the mucin
glycans. Because of this complexity and the variability of mucin
glycans, systematization of bacterial proteins for the degradation
of mucin glycans became the first goal of this study.
All bacterial proteins involved in the degradation of mucin
glycans were divided into two groups: (1) GHs, which split
glycans to oligo- and monosaccharides as well separating
glycans from mucin proteins, and (2) enzymes required for the
catabolism of the derived monosaccharides. This division was
made based on the following aspects of mucin glycan degradation
by the HGM. First, splitting of glycans and catabolism
of the derived monosaccharides are spatially separated; the
first process occurs outside of the microbial cell, while the
second process occurs in the cell cytoplasm. Such spatial
separation is important for the metabolic modeling of HGM-
host metabolism. Second, some HGM organisms have only
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glycan-cleaving hydrolases or only monosaccharide-catabolizing
enzymes. For example, Bacteroides thetaiotaomicron encodes
only sialidases that can release Neu5Ac from mucin glycans
but not genes for the catabolism of this compound (Marcobal
et al., 2011). On the other hand, Clostridium difficile encodes
only genes for the catabolism of N-acetylneuraminic acid
but not sialidases (Sebaihia et al., 2006). Such differentiation
of the enzymes provides for the cross-talk of the HGM
organisms, as was shown for B. thetaiotaomicron releasing
Neu5Ac and Salmonella typhimurium consuming it (Ng et al.,
2013). Thus, the distribution of the monosaccharide-releasing
enzymes and monosaccharide catabolic pathways should be
analyzed separately.
To identify all the GHs for mucin glycan degradation, we first
identified all the glycosyl bonds previously detected in mucin
glycans of the human intestine (Podolsky, 1985; Larsson et al.,
2009; Tailford et al., 2015), which resulted in a collection of
21 different glycosyl bonds (Figure 1A and Table S9). Then,
we searched for all the enzymes able to hydrolase such bonds
using the KEGG (Kanehisa et al., 2012) and MetaCyc (Caspi
et al., 2014) databases. Briefly, we searched the databases for both
of the monosaccharides that form the bond after the reactions
connected to this monosaccharide were filtered by EC number
to identify all the glycoside hydrolases (i.e., enzymes with EC
3.2.-.-) for which this monosaccharide can be a substrate or
product. After that, all the identified glycoside hydrolases were
manually checked for the corresponding analyzed bond. Finally,
we collected 9 types of GHs (Table S9). For further information
on these enzymes, such as protein families and experimentally
analyzed representatives, we carried out a search by EC number
in the CAZy database (Cantarel et al., 2012).
Pathways for catabolism of the derived monosaccharides were
identified here as sets of reactions necessary to convert the
monosaccharides into any intermediates of central metabolism.
The pathway data were extracted from the KEGG (Kanehisa
et al., 2012) and MetaCyc (Caspi et al., 2014) databases as well
as previous publications. For the two monosaccharides GalNAc
and GlcNAc, only one pathway per monosaccharide has been
described (Figure 1B). GalNAc is catabolized through tagatose 6-
phosphate to glyceraldehyde 3-phosphate and dihydroxyacetone
phosphate (Leyn et al., 2012; Bidart et al., 2014), whereas
GlcNAc is converted into fructose 6-phosphate (Afzal et al.,
2015a; Plumbridge, 2015; Uhde et al., 2016). For Fuc, Gal,
and Neu5Ac, two alternative pathways for the catabolism of
FIGURE 1 | Enzymes involved in the degradation of mucin glycans. (A) Splitting of a hypothetical mucin glycan by GHs. The following enzymes are shown: EC
3.2.1.18, Neuraminidase; EC 3.2.1.22, α-galactosidase; EC 3.2.1.23, Beta-galactosidase; EC 3.2.1.49, α-N-acetylgalactosaminidase; EC 3.2.1.50,
α-N-acetylglucosaminidase; EC 3.2.1.51, α-L-fucosidase; EC 3.2.1.52, β-N-hexosaminidase; EC 3.2.1.97, and Endo-α-N-acetylgalactosaminidase. (B) Known
pathways for utilization of the derived monosaccharides. Protein abbreviations are shown; for the corresponding functions see Table S2 in the Supplementary
Materials.
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each monosaccharide have been described. Thus, Fuc may be
catabolized through fuculose 1-phosphate to lactaldehyde and
dihydroxyacetone phosphate or through fucolactone to lactate
and pyruvate (Yew et al., 2006; Hobbs et al., 2013). For the
genes encoding enzymes of the latter pathway, no four-letter
abbreviations have been designated. Thus, for these genes,
we introduced the designation fclABCDE (from fucolactone;
the last letter corresponds to the order of catalyzed reactions
in the pathway). Gal catabolism can also occur through two
alternative pathways: through galactose 1-phosphate and UDP
galactose (the Leloir pathway) (Bettenbrock and Alpert, 1998;
Afzal et al., 2015b) or through galactose 6-phosphate and tagatose
6-phosphate (Zeng et al., 2010). The last two steps of the second
pathway, phosphorylation and aldol splitting, are shared with the
pathway for GalNAc catabolism. Neu5Ac is converted to fructose
6-phosphate by two pathways, through GlcNAc or GlcNAc 6-
phosphate (Vimr et al., 2004; Brigham et al., 2009). Therefore,
these pathways overlap with GlcNAc by two or three reactions,
respectively (Figure 1B).
Utilization of L-Fucose
Intestinal mucin glycans contain Fuc moieties connected to
Gal by α1,2-linkage as well to GlcNAc by α1,2-, α1,3-, or
α1,4- linkages (Podolsky, 1985; Tailford et al., 2015). During
the degradation of mucin glycans, these moieties can be
removed by α-L-fucosidases (Katayama et al., 2004; Nagae
et al., 2007; Ashida et al., 2009). α-L-fucosidases found
in the analyzed genomes belong to three families: GH29,
GH42, and GH95. At least one α-L-fucosidase was found
in 131 genomes (Table S3). All of these genomes belong
to only four phyla: Actinobacteria, Bacteroidetes, Firmicutes,
and Verrucomicrobia. The largest number of genes encoding
α-L-fucosidases were found in representatives of Firmicutes
(Lachnospiraceae bacterium 3_1_57FAA_CT1, 16 genes) and
Bacteroidetes (Bacteroides coprophilus DSM 18228, 14 genes).
Genes for both the alternative pathways for Fuc catabolism
were found in the analyzed genomes. Thus, genes for the
pathway through fuculose 1-phosphate (fucIKA genes) were
found in the 125 genomes belonging to all studied bacterial phyla
except Synergistetes and Tenericutes. The genes for the pathway
through fucolactone (fclABCDE) were found in only 8 genomes,
all belonging to Actinobacteria.
In total, three different Fuc-specific transport systems were
found in the analyzed genomes, including two different
permeases and one ABC transporter. The first permease, herein
referred to as FucP1, was previously analyzed in Escherichia coli
(Gunn et al., 1994) and predicted in the genomes of Bacteroides
spp. (Hooper et al., 1999; Ravcheev et al., 2013). This transporter
is highly distributed in the analyzed genomes, co-clustering
with the fuc genes in 88 genomes and with the fcl genes in 4
genomes. An alternative Fuc permease named FucP2 belongs to
the Sugar_tr family (Pfam: PF00083). The gene encoding this
transporter is located inside the fuc gene cluster in the genomes
of Pediococcus acidilactici and Lactobacillus rhamnosus. A third
fucose transporter, the ABC-type one, was predicted in this study
(see Prediction of Novel Fucose-Specific ABCTransport System).
This transporter was found in 33 genomes belonging mostly to
Actinobacteria and Clostridia.
Generally, α-L-fucosidases were found in 131 analyzed
genomes, whereas Fuc CPs were found in 133 genomes. Both α-
fucosidases and CPs were found together in 72 analyzed genomes
(Figure 2, Table S3).
Utilization of N-Acetyl-D-Galactosamine
GalNAc plays a crucial role in mucin glycans, forming
links with side-chain oxygen atoms of Ser/Thr residues in
FIGURE 2 | Distribution of the CPs and GHs for mucin glycan-derived monosaccharides in the analyzed genomes. Pathways and GHs are grouped according to the
utilized monosaccharide. The bars “CP” correspond to the presence of catabolic pathways, the bars “GH” correspond to the presence of glycosyl hydrolases, the
bars “CP+GH” correspond to the presence of GHs and pathways for this monosaccharide in the same genomes.
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mucin peptide chains. This linkage between the glycan and
peptide parts of mucin is mediated by various endo-α-N-
acetylgalactosaminidases (Ashida et al., 2008; Koutsioulis et al.,
2008; Kiyohara et al., 2012). Additionally, in intestinal mucin
glycans, GalNAc moieties can be connected to Gal by α1,3- ,or
β1,4-linkage and to GalNAc by α1,6- or β1,3-linkage (Podolsky,
1985; Tailford et al., 2015). Release of GalNAc from mucin
glycans can be mediated by β-N-hexosaminidases (Cabezas,
1989; Zwierz et al., 1999) and exo-α-N-acetylgalactosaminidases
(Hoskins et al., 1997).
At least one GalNAc-releasing GH (GalNAc-GH) was found
in 218 genomes (Table S4). No GalNAc-GHs were found in the
genomes of Archaea or in the bacterial phyla Fusobacteria and
Synergistetes. The maximal number of genes for the GalNAc-
GHs was found in Bacteroides sp. 1_1_6 and Bacteroides sp.
D22. Both of these organisms have 17 GalNAc-GH genes per
genome. All exo-α-N-acetylgalactosaminidases in the analyzed
genomes belong to the GH27 family. This type of GalNAc-GHs
were found in only 13 genomes belonging to only four phyla:
Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria.
Endo-α-N-acetylgalactosaminidases are also rarely represented
in the analyzed genomes. These enzymes, belonging to the
GH101 or GH129 families, were found in only 15 genomes
from only two phyla: Actinobacteria and Firmicutes. In contrast,
β-N-hexosaminidases were found in 217 genomes and in all
bacterial phyla except Fusobacteria and Synergistetes. All the β-
N-hexosaminidases found in the analyzed genomes belong to the
GH3 or GH20 families.
GalNAc utilization pathway including agaS and agaA genes
(see Annotation of Homologous Enzymes for GalNAc and
GlcNAc Metabolism for Details on Annotation) was found in
76 analyzed genomes. Three different GalNAc-specific transport
systems were found in the analyzed genomes, the PTS-type
transporters AgaPTS and GnbPTS (see Annotation of the
GalNAc-Specific Transporters for Details on Annotation), as well
ABC-type transporter LnbABC. The GnbPTS is a transporter
with multiple specificities and, in addition to GalNAc it can also
transport oligosaccharides, lacto-N-biose (Galβ-1,3-GlcNAc),
and galacto-N-biose (Galβ-1,3-GalNAc) (Bidart et al., 2014).
Both lacto-N-biose and galacto-N-biose contain the glycosyl
bonds found in intestinal mucin glycans (Table S9). Thus,
GnbPTS was included in the three analyzed pathways as GalNAc,
GlcNAc, and Gal catabolism. Lacto- and galacto-N-biose are then
hydrolyzed by intracellular GH GnbG. Formally, GnbG is a GH,
but because of its intracellular localization, it is considered to be a
part of the GalNAc, GlcNAc and Gal CPs. The LnbABC transport
system also transports lacto- and galacto-N-biose that afterwards
hydrolyzed by intracellular phosphorylase LnbP (Nishimoto and
Kitaoka, 2007). As with GamPTS-GamB, the LnbABC-LnbP
system was considered to be a part of the GalNAc, GlcNAc and
Gal CPs.
Overall, the GalNAc CP was found in the 76 analyzed
genomes belonging to the phyla Actinobacteria, Firmicutes, and
Proteobacteria (Figure 2, Table S4). Distribution of the GalNAc-
releasing GHs is much broader; these enzymes were found in 218
genomes. Both GHs and CPs were found in only 27 of analyzed
genomes.
Utilization of N-Acetyl-D-Glucosamine
Intestinal mucin glycans contain GlcNAc moieties that form
various glycosyl bonds, such as α1,4-, and β1,3-linkages with
Gal and β1,3-, and β1,6-linkages with GalNAc (Podolsky,
1985; Tailford et al., 2015). The α-linkages are hydrolyzed
by α-N-acetylglucosaminidases (Shimada et al., 2015), whereas
the β-linkages with Gal or GalNAc are hydrolyzed by β-N-
hexosaminidases (see Utilization of N-Acetyl-D-Galactosamine).
At least one GlcNAc-releasing GH (GlcNAc-GH) was found
in 257 genomes (Table S5). The maximal numbers of the
genes encoding GlcNAc-GHs were found in Bacteroides sp.
1_1_14 (23 genes) and B. thetaiotaomicron (22 genes). In
addition to β-N-hexosaminidases (see Utilization of N-acetyl-
D-Galactosamine), α-N-acetylglucosaminidases (GH89 family)
were found in 60 genomes (Table S5). All genomes in which α-
N-acetylglucosaminidase genes were found belong to the phyla
Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, and
Verrucomicrobia.
The GlcNAc CP (Yang et al., 2006; Plumbridge, 2015)
was found in 218 of the analyzed genomes (Table S5). This
pathway is broadly distributed among analyzed taxa and is
absent only in Archaea and the bacterial phyla Synergistetes and
Verrucomicrobia. Various GlcNAc-specific transport systems
were identified in the analyzed genomes. These are the
PTSs NagE (Plumbridge et al., 1993; Plumbridge, 2015) and
GnbPTS (see Utilization of N-Acetyl-D-Galactosamine), the
ABC transport systems NgcEFG (Xiao et al., 2002), NgcABCD
(predicted in this work, see Prediction of a Novel GlcNAc-
Specific Transporter) and LnbABC (Nishimoto and Kitaoka,
2007), and the permease NagP (Ravcheev et al., 2013).
The GlcNAc moieties of intestinal mucin glycans can be
sulfated. This sulfation possibly protects these glycans from
degradation by the HGM and is correlated with health and
disease status of the host organism (Tobisawa et al., 2010; Boltin
et al., 2013). Only specific microbial species are able to remove
sulfate groups to make mucin glycans available for themselves
or to other microbes (Smalley et al., 1994; Robertson and
Wright, 1997; Jansen et al., 1999; Wright et al., 2000; Robinson
et al., 2012). Among the analyzed organisms, genes for mucin-
desulfating sulfatase (GlcNAc-6-sulfatase) were found only in
42 genomes from Bacteroidetes phyla and in the genome of
A. muciniphila (Table S5). Notably, more than half of these genes
are chromosomally clustered with the nagKP operon or with
genes for β-N-hexosaminidases (Figure S8).
Overall, GlcNAc CP was found in 218 analyzed genomes,
whereas GlcNAc-GHs were found in 266 genomes. Both the
pathway and the GHs were found in 155 analyzed genomes
(Figure 2, Table S5).
Utilization of N-Acetyl-D-Neuraminic Acid
Neu5Ac is commonly found in the terminal location of intestinal
mucin glycans (Johansson et al., 2011; Mcguckin et al., 2011),
forming α2,3-linkages with Gal and α2,6-linkages with Gal or
GalNAc (Tailford et al., 2015). These bonds can be hydrolyzed by
sialidases (Juge et al., 2016). Sialidases, all belonging to the GH33
family, were found in 112 analyzed genomes. Sialidases were
found in the genomes of all bacterial phyla except Fusobacteria
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and Synergistetes. The maximal number of sialidase-encoding
genes was found in Bacteroides fragilis 638R and Bacteroides sp.
D22 genomes (7 genes per genome).
Two CPs for Neu5Ac have been described previously (Vimr
et al., 2004; Brigham et al., 2009). These pathways can be
distinguished by the sugar epimerases; the first pathway is
characterized by the presence of N-acetylmannosamine-6-
phosphate 2-epimerase (NanE), whereas the second pathway
is characterized by the presence of N-acetylglucosamine
2-epimerase (NanE-II) (Figure 1B). These epimerases are
homologous to each other, and to distinguish them, we
constructed amaximum-likelihood phylogenetic tree (Figure S9).
Nonetheless, NanE and NanE-II are homologs; they form clearly
distinguishable monophyletic branches on the tree. Thus, the first
Neu5Ac CP, with the NanE enzyme, was found in 131 analyzed
genomes, belonging to the phyla Actinobacteria, Firmicutes,
Fusobacteria, and Proteobacteria. The second pathway, with
the NanE-II enzyme, was found in 56 genomes. Most of these
genomes are Bacteroidetes, only 3 of them belong to Firmicutes,
and A. muciniphila is a representative of Verrucomicrobia.
The CPs were found in 187 analyzed genomes, belonging
to all bacterial phyla with the exception of Synergistetes and
Tenericutes. For Neu5Ac, various types of transporters have been
previously described (Thomas, 2016). In the analyzed genomes,
we identified the following Neu5Ac transporters: an MFS-type
transporter (NanT), a sodium solute symporter (NanX), two
ABC transport systems (NanABC and NanABC2), and a TRAP
transport system (NeuT) (Table S7). No novel genes for Neu5Ac
transport or catabolism were predicted.
The Neu5Ac CPs were found in 189 analyzed genomes, while
both the pathways and the sialidases were found in only 80
analyzed genomes.
Utilization of D-Galactose
In human intestinal mucin glycans, Gal can form α1,3-linkages
with other Gal, β1,3-linkages with GalNAc and GlcNAc, and
β1,4-linkages with GlcNAc (Podolsky, 1985; Tailford et al., 2015).
These linkages can be hydrolyzed by various α- (Wakinaka et al.,
2013; Han et al., 2014; Reddy et al., 2016) and β-galactosidases
(Husain, 2010; Park and Oh, 2010; Michlmayr and Kneifel, 2014;
Solomon et al., 2015). At least one galactosidase gene was found
in 310 analyzed genomes, belonging to all bacterial phyla except
Synergistetes. The maximal numbers of galactosidase genes were
found in Bacteroides cellulosilyticus DSM 14838 (56 genes) and
Bacteroides sp. D2 (50 genes). The α-galactosidases found in
the analyzed genomes belong to families GH4, GH27, GH36,
and GH43, whereas the β-galactosidases belong to families GH2,
GH35, and GH42.
For Gal utilization, two alternative pathways are possible.
The Leloir pathway, in which Gal is utilized through UDP
galactose (Bettenbrock and Alpert, 1998; Afzal et al., 2015b),
was found in 335 analyzed genomes belonging to all bacterial
phyla except Synergistetes. The 256 of these genomes contained
the galU and galT genes for uridylyltransferases, whereas the 70
other genomes contained the galY gene, which was predicted
to be a non-orthologs displacement of the galT (see Prediction
of a Non-orthologs Replacement for the Uridylyltransferase
GalT). The alternative pathway, the utilization of Gal through
tagatose 6-phosphate (Zeng et al., 2010), was found in only 29
analyzed genomes, belonging to Actinobacteria and Firmicutes.
Surprisingly, genes for the Leloir pathway were also found in all
29 of these genomes.
Four previously known Gal transporters were found in the
analyzed genomes. These are galactose (Essenberg et al., 1997)
and galactose/lactose (Luesink et al., 1998) permeases, here
referred to as GalP1 and GalP2, respectively; the galactose/methyl
galactoside ABC transport system Mgl (Weickert and Adhya,
1993); and the galactose-specific PTS (Zeng et al., 2012). Also,
we predicted a new Gal-specific transporter from the SSS family
(sodium solute symporter, Pfam: PF00474), here referred to as
GalP3 (see Prediction of a Novel Galactose-Specific Transporter).
The gene for this transporter was found to be co-clustered with
the genes for the Leloir pathway in 20 analyzed genomes and
with galactosidases in 16 analyzed genomes, that corroborate
the predicted function. Additionally, Gal can be imported into
the cell as part of lacto-N-biose and galacto-N-biose by the
GnbPTS and/or LnbABC systems (see Utilization of N-Acetyl-
D-Galactosamine and Utilization of N-Acetyl-D-Glucosamine).
Gal CPs were found in 355 analyzed genomes, whereas both
Gal-GHs and the pathways were found in 296 genomes.
DISCUSSION
Distribution of GHs and CPs in the
Analyzed HGM Genomes
In this study, we analyzed the distribution of genes required
for utilization of mucin glycans in 397 genomes of microbes
found in the human gastrointestinal tract. The analyzed genes
encode extracellular enzymes for cleavage of mucin glycans to
monosaccharides as well as transport proteins and enzymes for
subsequent utilization of the derived monosaccharides. These
genes were conditionally divided into five groups, representing
the five monosaccharides found in mucin glycans. Each of
these monosaccharide-specific groups of genes can, in turn,
be subdivided into extracellular GHs (Figure 1A) and genes
for monosaccharide-utilizing CPs (Figure 1B). Analyzing the
distribution of glycan-utilizing genes, we observed two general
trends: (1) numerous genomes contain only CPs or only GHs and
(2) pathways for different monosaccharides are distributed very
differently from each other (Figure 2).
The presence of only CPs or only GHs has been previously
described for the metabolism of Fuc (Pacheco et al., 2012;
Conway and Cohen, 2015) or Neu5Ac (Ng et al., 2013) in the
HGM. Nonetheless, such partial pathways have been previously
described for only some HGM genomes. Here, our results
demonstrated that such partial pathways are characteristic for
the degradation of mucin glycans by the HGM. Thus, 339
(85%) of the analyzed genomes have a partial pathway for
at least one of the mucin-derived monosaccharides. Generally,
726 partial pathways were found, including 312 cases with
the presence of only CPs and 414 cases with the presence
of only GHs (Table S10). Such a wide distribution of partial
pathways indicates the existence of multiple potential feeding
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pathways for mucin glycan-derived monosaccharides in the
HGM (see Possible Feeding Pathways for the Analyzed HGM
Genomes).
A distinct distribution of pathways for utilization of
the analyzed monosaccharides has not been described
previously at the level of large microbial communities,
such as the HGM. At the level of monosaccharide-
specific CPs, sorting by the number of genomes where
they were found produces the following sequence:
Gal>GlcNAc>Neu5Ac>Fuc>GalNAc. A similar sequence
was found for the GHs: Gal>GlcNAc>GalNAc>Fuc>Neu5Ac.
The differences between these two sequences can be explained
as follows. (1) GHs specific for Fuc and Neu5Ac were found
in 72 and 80 genomes, respectively. Therefore, their switching
places may be the result of a minor bias caused by the selection
of the analyzed genomes. Because only genomes available in
the HMP, KEGG and PubSEED databases were analyzed (see
Approach, Tools, and Databases), the set of selected genomes
is slightly biased. Thus, the set of analyzed genomes is enriched
by genomes of Proteobacteria, especially by Enterobacteriales.
(2) This difference also indicates that gastric mucin glycans
are mainly neutral and that sialylation of them is quite rare
(Rossez et al., 2012). (3) The higher number of genomes with
GalNAc-GHs in comparison with Fuc- and Neu5Ac-GHs can
be explained by the fact that the majority of GalNAc-GHs are
β-hexosaminidases, which are enzymes specific to GalNAc
and GlcNAc. This explanation is in good agreement with
the large number of genomes having GlcNAc-specific CPs
and/or GHs.
The different distributions of pathways for different
monosaccharides may be due to their dissemination in
nature, particularly in the human intestine. Therefore, in
animals, Fuc and Neu5Ac are found mostly on terminal units
of carbohydrate chains linked to proteins or lipids (Staudacher
et al., 1999; Vimr, 2013; Pickard and Chervonsky, 2015). GalNAc
is a slightly more disseminated since it is not only a terminal
monosaccharide but also acts as a connecting link between the
glycan and protein portions of N- and O-linked proteoglycans
(Ashida et al., 2008; Koutsioulis et al., 2008; Kilcoyne et al.,
2012; Kiyohara et al., 2012). Thus, in the human intestine, these
three monosaccharides are parts of host-synthesized glycans or
are derived from dietary components of animal origin. GlcNAc
is much more broadly disseminated and, in addition to being
found in glycoproteins, it can be found in heparin, chondroitin
sulfate, hyaluronan, and various human milk oligosaccharides
(HMOs) (Lamberg and Stoolmiller, 1974; Garrido et al., 2011).
Gal is even more broadly disseminated than GlcNAc and can
be found in both animal- or plant-synthesized polysaccharides.
Thus, Gal is a building block of arabinogalactan, pectic galactan,
and HMOs. As a component of side chains, Gal may be found
in type II rhamnogalacturonan and as a terminal unit in α-
mannans, galactomannan, xyloglucan, and xylan (Kunz et al.,
2000; Mohnen, 2008; Garrido et al., 2011; Marcobal et al., 2011).
To confirm that the distribution of monosaccharide-
utilizing pathways and monosaccharide-specific GHs reflects
dissemination of these monosaccharides in nature, we analyzed
data for these monosaccharides from the KEGG database. For
each of the monosaccharides, two parameters were analyzed: (1)
the number of reactions that the monosaccharide is involved
in as a product or a substrate and (2) the number of glycans
containing this monosaccharide (Figure S10). The numbers
of reactions and glycans for the monosaccharides are in
line with the distribution of CPs and GHs in the analyzed
genomes. Thus, analysis of the numbers of reactions for
each monosaccharide resulted in the following sequence:
Gal>GlcNAc>Neu5Ac>Fuc>GalNAc, which is identical
to the sequence for genomes with monosaccharide-specific
CPs. For the number of glycans, the sequence is as follows:
Gal>GlcNAc>Fuc>GalNAc>Neu5Ac, which is similar to the
sequence for genomes with monosaccharide-specific GHs.
Examining the variation of the monosaccharide-specific
pathways, we wondered how the combinations of the utilized
monosaccharides varied across the HGM genomes. Because
only CPs or only GHs were found in 85% of the genomes,
combinations of CPs and GHs were analyzed separately. We
used binary information regarding the distribution of pathways
in 397 HGM genomes, i.e., the presence or absence of a CP
or GH in a genome (Table S10). We investigated the 25 =
32 possible patterns of the eight studied pathways. Only 22
(69%) and 19 (60%) of the 32 possible patterns were found
for CPs and GHs, respectively. The most frequent pattern for
CPs represents catabolism of only Gal and GlcNAc. This pattern
was found in 59 analyzed genomes, including Bifidobacteriacea,
various Firmicutes, and Fusobacteria. Other frequently observed
CP patterns are as follows: (1) absence of CPs for any analyzed
monosaccharides, (2) utilization of all monosaccharides except
GalNAc, (3) utilization of Gal only, and (4) utilization of Gal
and Neu5Ac only. The most frequent pattern for GHs is the
presence of GHs specific to all five monosaccharides. This
pattern was found in 81 genomes, including someActinobacteria,
multiple Bacteroidetes, Firmicutes (mostly belonging to the
Lachnospiraceae family), and A. muciniphila. Other frequently
observed GH patterns are as follows: (1) presence of GHs specific
to GalNAc, GlcNAc, and Gal; (2) absence of GHs for any analyzed
monosaccharides; (3) presence of only Gal-specific GHs; and (4)
presence of only GlcNAc- and Gal-specific GHs.
Theoretically, the combination of the observed CP and GH
patterns should result in 22∗19 = 418 combined patterns;
however, only 102 (24%) of them were actually observed,
which indicates interdependence of GHs and CPs. This
interdependence appears to be rather trivial because only non-
digestible carbohydrates are available for HGM organisms,
especially in the large intestine (Walker et al., 2011), so CPs are
highly dependent on GHs. On the other hand, no significant
correlations were observed between CP and GH patterns.
Together with CP dependence on GH repertoire, this absence of
correlations again indicates the possibility of intensive feeding by
mucin-derived monosaccharides in the HGM.
A non-random character of the CP and GH distribution
patterns was also confirmed by statistical Chi-squared testing.
Such a testing was done for three types of distributions, CP
patterns, GH patterns, and combined CP-GH patterns and
resulted in the following output parameters. (1) For the CP
patterns Chi-squared test results were X-squared = 727.51,
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degree of freedom (DF) = 31, and p-value < 2.2e-16. (2) For the
GH patterns the test results were X-squared = 1303, DF = 31,
and p-value< 2.2e-16. (3) For the combined CP-GH patterns the
test results were X-squared = 10418, DF = 1023, and p-value <
2.2e-16. Thus, the tests showed that the distributions of all three
pathways were non-random.
Surprisingly, the combined pattern corresponding to the
most frequent GH and CP patterns was found in only
three genomes: Clostridium nexile DSM 1787, Lachnospiraceae
bacterium 2_1_46FAA, and Ruminococcus lactaris ATCC 29176.
The combined pattern we observed most frequently was the
absence of all analyzed GHs and CPs. This pattern was found in
28 genomes, belonging to Archaea, some Firmicutes, and Beta-
and Epsilonproteobacteria. Other frequently observed combined
patterns were as follows: (1) presence of GHs specific for GalNAc,
GlcNAc, and Gal together with CPs for GlcNAc and Gal; (2)
presence of GHs for all five monosaccharides together with
utilization of all these monosaccharides except GalNAc; and
(3) presence of GHs for all five monosaccharides together with
utilization of Neu5Ac and Gal.
Taken together, an optimal strategy for glycan-utilizing HGM
microorganisms includes (1) the presence of CPs specific to
GlcNAc andGal as the components of multiple host- and dietary-
derived carbohydrates and (2) the presence of GHs specific to as
large as possible a number of glycan-building monosaccharides.
Possible Feeding Pathways for the
Analyzed HGM Genomes
The presence of only CPs for a certain monosaccharide in
one HGM organism and only GHs for this monosaccharide in
another organism allows us to predict possible feeding pathways.
Previously, such feeding pathways in the HGM have been
found for Fuc (Pacheco et al., 2012; Conway and Cohen, 2015)
and Neu5Ac (Ng et al., 2013). Here, we predicted multiple
potential feeding pathways for all five monosaccharides forming
mucin glycans. The 339 (85%) analyzed genomes demonstrated
the presence of only CPs or only GHs for at least one
monosaccharide; therefore, the majority of HGM organisms are
involved in these feeding pathways.
Based on the presence or absence of CPs and GHs, each
organism can be classified as a “donor” (having GHs but not CPs)
or “acceptor” (having CPs but not GHs) in relation to a certain
monosaccharide. Among the analyzed genomes, 181 (46%)
organisms can only be “donors” while 103 (33%) organisms can
only be “acceptors” for the studied monosaccharides (Table S10).
Additionally, 55 (14%) organisms were classified as “mixed”,
being “donors” for some monosaccharides and “acceptors” for
others.
In summary (Figure 3 and Tables S10, S11), data on
possible feeding pathways demonstrate the following features
of utilization of mucin-derived monosaccharides in the HGM:
(1) larger number of “donors” relative to “acceptors” and (2)
taxonomy-specific distribution of donors and acceptors.
Generally, 414 “donor” roles were found to be distributed
among 236 genomes, whereas 312 “acceptor” roles were
found to be distributed among 158 genomes. The significant
predominance of “donors” reflects an adaptation of the analyzed
organisms to the environment of the human intestine. No free
monosaccharides are available in the large intestine (Walker
et al., 2011), so the only way for HGM organisms to obtain
monosaccharides is the cleavage of polysaccharides that are non-
digestible for the host. Thus, HGM organisms should have GHs
not only for monosaccharides that they can catabolize but also
for all monosaccharides present in the available polysaccharides.
Additionally, the appearance of a new “donor” role during
evolution is much more probable than the appearance of a new
“acceptor” role. With the appearance of a “donor,” only one new
function should be acquired through horizontal gene transfer or
duplication and neofunctionalization of the GH-encoding gene.
Indeed, horizontal transfer has been previously demonstrated for
genes encoding sialidase (Roggentin et al., 1993). In contrast,
the appearance of a new “acceptor” requires horizontal transfer
of multiple genes for enzymes and transporters. Because genes
for CPs are not always encoded as a single locus (Leyn et al.,
2012; Ravcheev et al., 2013; Rodionov et al., 2013; Khoroshkin
et al., 2016), horizontal transfer of all genes required for
the catabolism of a certain monosaccharide would be nearly
impossible. Similarly, the appearance of a new CP through
duplication and neofunctionalization requires the simultaneous
change of specificities for multiple genes, which is also very
unlikely.
The distribution of “donor” and “acceptor” roles among
the analyzed genomes is taxon-specific (Figure 3). Thus, no
“donors” were found among Fusobacteria, and no “acceptors”
were found among Tenericutes and Verrumicrobia. Among
Bacteroidetes, only 2 strains of Bacteroides eggerthii were
identified as “acceptors,” whereas 62 strains from this group
were identified as “donors.” The opposite is observed for
Proteobacteria, for which only 9 genomes can be “donors”
and 51 genomes can be “acceptors.” At the phylum level, the
most intensive exchange of monosaccharides should be between
“donor” Bacteroidetes and “acceptor” Proteobacteria, especially
between different Bacteroides spp. various strains of Escherichia
coli (Figure 3). Thereby, potential feeding pathways in the HGM
are formed by the interaction of two factors, (1) evolutionary
history of microbial taxa and (2) adaptation of HGM organisms
to the intestinal environment.
Specificity of the HGM Organism to Mucin
Glycans
Mucin glycans are complex polysaccharides characterized by a
variety of monosaccharide building blocks and bonds between
these monosaccharides (Martens et al., 2009; Koropatkin et al.,
2012; Rossez et al., 2012; Johansson et al., 2015; Tailford et al.,
2015). Tens of mucin glycan motifs and structures have been
described to date. These structures vary in terms of both
monosaccharides and glycosidic bonds (Podolsky, 1985; Rossez
et al., 2012; Tailford et al., 2015). Furthermore, the analyzed
genomes vary in the patterns of GHs able to cleave mucin glycans
(Table S10). Thus, we proposed that the analyzed organisms
should demonstrate some preferences for cleaved mucin
glycans.
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FIGURE 3 | Distribution of monosaccharide donors and acceptors by taxa. Only genomes classified as “donors” (the horizontal axis) and “acceptors” (the vertical axis)
are shown. The numbers of monosaccharides are shown in agreement with the color scale. For details on each pair of organisms and possibly exchanged
monosaccharides, see Table S11.
Data on the known structures of mucin glycans found in the
human intestine were collected from the literature (Podolsky,
1985; Rossez et al., 2012), resulting in 56 different glycan
structures (Figure S11 and Table S12). For each analyzed genome,
the ability to cleave each glycan structure was predicted. Glycan
was considered able to be cleaved by a certain organism if the GHs
for all glycoside bonds in the glycan were found in the genome
of the organism. Bonds between GalNAc and Ser/Thr residues
of the mucin peptide were excluded from the analysis because
this bond is cleaved by endo-α-N-acetylgalactosaminidases found
in only 15 of the analyzed genomes (Table S4). On the basis of
this prediction for each genome, the pattern of likely cleaved
glycans was determined (Table S13). Among 397 analyzed
genomes, 321 (81%) were able to cleave at least one of the
glycans; generally, 20 different glycan-cleavage patterns were
defined. It has previously been estimated that approximately
40% of bacteria have glycan-degrading enzymes (Arike and
Hansson, 2016). Here, we demonstrated that, at least for
the HGM microbes, this figure is actually at least 2-fold
higher.
Based on the glycan-cleavage patterns, only 8 analyzed
organisms are able to cleave all 56 glycan structures belonging
to the phyla Bacteroidetes (Bacteroides ovatus SD CMC
3f, Bacteroides sp. 2_2_4, and Bacteroides sp. 3_1_23) and
Firmicutes (Clostridium perfringens WAL-14572, 3 strains of
Lachnospiraceae bacterium, and Ruminococcus torques ATCC
27756). The three most frequently observed patterns were the
following. (1) Only Core 1 (Tailford et al., 2015) structures
can be cleaved, i.e., no GHs except β-galactosidases are present.
This pattern was found in 77 genomes belonging mostly
to Lactobacillaceae, Ruminococcaceae and Enterobacteriales.
(2) Glycans having only poly-lacto-N-biose but lacking any
specific groups (Table S12) can be cleaved. These genomes have
only GHs for the hydrolysis of β-Gal and β-GlcNAc bonds.
This pattern was found in 56 genomes belonging mostly to
Actinobacteria, Firmicutes and Enterobacteriales. (3) All glycans
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lacking α-GalNAc groups can be cleaved. These genomes have
all GHs but not α-N-acetylgalactosaminidases. This pattern was
found in 41 genomes belonging mostly to Bacteroidaceae.
Based on the repertoire of possibly hydrolyzed mucin glycans,
the analyzed genomes can be classified as generalists or specialists
as follows. (1) Organisms predicted to degrade 1 to 3 glycans were
classified as specialists. (2) Organisms predicted to degrade 21 to
56 glycans were classified as generalists. (3) Organisms predicted
to degrade 5 to 13 glycans were classified as intermediate
strains. Distribution of generalists, intermediates, and specialists
was clearly taxon-specific (Figure 4 and Table S13). Thus,
most of the analyzed Actinobacteria are intermediates. In this
taxon, there are also some generalists and specialists, with the
larger number of generalists than specialists. An overwhelming
majority of Bacteroidetes are generalists, whereas intermediates
and specialists are exceptional in this taxon. Proteobacteria, on
the contrary, are mostly specialists and no one generalist was
found in this taxon. Firmicutes contain almost equal numbers of
generalists and intermediates and slightly more specialists than
generalists or specialists.
The predicted glycan-cleavage patterns demonstrate some
taxon-specific features. For example, for 66 genomes of glycan-
cleaving Bacteroidetes, only 8 patterns were identified, whereas
for 46 genomes of glycan-cleaving Proteobacteria, only 4 patterns
were identified. Thus, the glycan-cleavage abilities of HGM
organisms also depend on the evolutionary history of the taxon,
though the correlation between these abilities and taxonomy
is not so strong. On the other hand, mucin glycans can also
be cleaved by multistrain communities in which each strain
hydrolyzes a part of the glycosyl bonds (Figure 5).
An ability of HGM microbes to degrade different glycans has
been previously determined using the GlyDeR pipeline (Eilam
et al., 2014). This study included the analysis of 196 strains
(Table S14) and 9 mucin glycans (namely, glycans 1, 11, 22,
24, 30, 44, 50, 51, and 54, see Figure S11) that overlapped
with our work. Both studies predicted that 89 (45.4%) genomes
cannot degrade mucin glycans. A total of 79 (40.3%) genomes
were predicted to degradate mucin glycans only in the present
study. For 22 genomes (11.2%), the glycan degradation was
predicted by both studies, but the current study predicted more
glycans. Six genomes (3.1%) were predicted by both studies, but
GlyDeR pipeline predicted more glycans. Such a big differences
between results of this work and GlyDeR-based predictions can
be explained by the following reasons. (1) The GlyDeR pipeline
is developed for a large-scale automated analysis, whereas this
work was concentrated only on known intestinal mucin glycans.
(2) In the GlyDeR pipeline, GHs are predicted by their similarity
to proteins represented at the CAZy database (Cantarel et al.,
2012) whereas we used as a query GHs extracted from multiple
databases. In addition to CAZy, we used the UniProt (Magrane
and Consortium, 2011), KEGG (Kanehisa et al., 2012), and
MetaCyc (Caspi et al., 2014), as source of the query protein
sequences. (3) The GlyDeR uses one-direction BLAST search for
prediction of the GH specificities whereas here a bi-directional
search together with an analysis of the protein domain structures
and of the genome context was used. One-directional search
often results in inexact functional annotations, especially for large
protein families. For example, among GHs degrading human
intestinal mucin glycans, there are two enzymes belonging to the
GH42 family, the α-L-fucosidase and β-galactosidase (Table S2).
Inaccurate annotations for these enzymes can sufficiently change
the pattern of potentially degraded glycans. (4) The approach
used in this study estimates an ability of the organism to
degrade certain glycan as a Boolean function, answering to the
question “Can this organism degrade this glycan?” by “yes/no.” In
contrast, the GlyDeR pipeline estimates a specific score, and the
“yes/no” answer depends on the threshold selected for this score.
The GlyDeR scores for all the glycans analyzed in the both studies
are <0.05 (Table S14), which is low. For example, the minimal
non-zero GlyDeR score for lactose is a 0.3333 (Eilam et al., 2014).
It appears that GlyDeR provides an estimation of the glycolytic
potential for a large number of glycans, whereas an approach used
in this study is better for detailed analysis of a small number of
structurally related glycans.
A minimal multistrain community should include two
different strains. Here, we proposed the existence of mutualistic
pairs of HGMorganisms.We defined a predictedmutualistic pair
as a pair of organisms that can cleave more mucin glycans than a
FIGURE 4 | Generalists and specialists in degradation of mucin glycans. Total numbers of the analyzed genomes are shown right to tabs. No information is shown for
Archaea (both analyzed organisms are non-degrading) and taxa with one analyzed genome, Synergistetes (non-degrading), Tenericutes (generalist), and
Verrucomicrobia (generalist).
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FIGURE 5 | Cleavage of a hypothetical mucin glycan by a community of HGM inhabitants. For each reaction, the taxa with the corresponding specific GHs are shown.
union of the glycan-cleavage patterns of these two organisms. To
predict such mutualistic pairs, we used the following procedure.
(1) All possible pairs of the studied genomes were analyzed with
the exception of pairs in which at least one of the organisms
can cleave all 56 glycan structures (Figure S11). (2) For each of
the analyzed pairs, two glycan-cleavage patterns were predicted.
(3) The so-called “summary pattern” was defined as a union of
the patterns for each organism in the pair. (4) The so-called
“mutualistic pattern” was defined as a pattern predicted on the
basis of the GHs present in both genomes. (5) For a pair of
genomes, the common set of GHs was considered to be the sum
of GHs found in each genome. (6) For the common set of GHs,
the ability to cleave each glycan structure was predicted. (7) All
the glycans able to be cleaved by the common set of GHs formed
the “mutualistic pattern” for this pair of organisms. (8) If the
“mutualistic pattern” contained glycans absent in the “summary
pattern,” this pair of organisms was predicted to be a mutualistic
one. In total, 325 (82%) analyzed genomes were able to form
mutualistic pairs (Figure 6 and Table S14).
The predicted mutualistic pairs able to cleave all 56 glycan
structures were considered to be highly beneficial. Thus, in
agreement with predicted glycan-cleavage patterns, Collinsella
stercoris DSM 13279 and Clostridium spiroforme DSM 1552 can
cleave 27 different glycans each, Eubacterium dolichum DSM
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FIGURE 6 | Mutualistic pairs for cleavage of mucin glycans. The numbers of cleaved glycans are shown in agreement with the color scale. The numbers of glycans
cleaved by single organisms are shown for all genomes. For the pairs of organisms, the numbers of cleaved glycans are shown only for mutualistic pairs. For details
on each mutualistic pair of organisms and cleaved glycans, see Table S15.
3991 can cleave 9 glycans, and Cedecea davisaeDSM 4568 cannot
cleave any mucin glycans. Each of these genomes can form
highly beneficial pairs with various Bacteroides spp. that alone
can cleave 40–41 glycans. Clostridium celatum DSM 1785 has a
glycan-cleavage pattern that includes 50 glycans. This genome
can form highly beneficial pairs with Bifidobacterium spp. that
can cleave 2–22 glycans, with Lactobacillus spp. that can cleave
0–22 glycans, and with Enterobacteriaceae that can cleave 0–9
Frontiers in Genetics | www.frontiersin.org 15 August 2017 | Volume 8 | Article 111
Ravcheev and Thiele Degradation of Mucin Glycans by HGM
glycans. All highly beneficial pairs described are organized in
a similar manner. The five strains listed above are distantly
related to each other, and three of them, C. celatum, C. davisae,
and C. spiroforme, are pathogens (Akinosoglou et al., 2012;
Papatheodorou et al., 2012; Agergaard et al., 2016), whereas no
data about the pathogenicity of C. stercoris and E. dolichum
were found. Each of these five strains forms highly beneficial
pairs with a large number of organisms closely related to each
other and highly represented in healthy HGM (Eckburg et al.,
2005; Goodman et al., 2011; Walker et al., 2011; Graf et al.,
2015). Based on these features of highly beneficial pairs, we
proposed that these five organisms can be harmful to human
health not only due to pathogenicity itself but also because they
can greatly increase the ability of the HGM to forage the host
mucus layer.
The idea of mutualistic pairs is quite attractive but rather
speculative at this stage, as it requires additional support, such
as ecological-statistical testing of its relevance. One would need
to test how many of such pairs co-occur in actual human gut
samples compared to a random co-occurrence model. However,
such analysis is associated with some challenges. For instance,
the HGM taxonomical structure significantly varies depending
on host genetics, age, geography, lifestyle, and diet (Kurokawa
et al., 2007; Clemente et al., 2012; Yatsunenko et al., 2012;
Suzuki and Worobey, 2014; Allais et al., 2015). For example,
only 75 microbial species were found in more than 50% of
individuals (Qin et al., 2010). Second, HGM is characterized
by functional redundancy, namely the same functions can be
conferred by multiple bacteria, both closely or distantly related
to each other (Moya and Ferrer, 2016). The predicted mutualistic
pairs illustrate this redundancy. For example, C. stercoris was
predicted to formmutualistic pairs, i.e., having an identical sets of
mucin glycans degraded by the pair, with such a distantly related
organisms as A. muciniphila, B. thetaiotaomicron, C. nexile, and
Streptomyces sp. HGB0020 (Table S15). Finally, the results of the
testing may be biased because of the closely related organisms
that can be present in the HGM. For example, C. stercoris can
form identical predicted mutualistic pairs with the 43 different
Bacteroides spp. (Table S15). If different, but closely related to
each other, Bacteroides spp. will be present in samples from
different individuals, this testing will not demonstrate a co-
occurrence of C. stercoris with any of these strains in comparison
with a random co-occurrence. Taken together, idea of the
mutualistic pairs in the HGM is a perspective area for further
studies.
Unresolved Problems and Possible
Solutions
This study resulted in the prediction of a number of novel genes
involved in utilization of human mucin glycans. Nonetheless,
some problems related to monosaccharide utilization remain
unresolved (Tables S3–S8). These problems are the absence of
one or two steps of certain CPs as well as the absence of known
transporters in the presence of a corresponding CP. At least
one such problem was detected for 90 (23%) of the analyzed
genomes. The most frequently observed problems are as follows:
(1) the absence of known Gal transporters in 30 genomes, mostly
Firmicutes; (2) the absence of L-fuculose phosphate aldolase in
23 genomes belonging to Bacteroidetes, Clostridia, and some
Actinobacteria; (3) the absence of L-fuculokinase in 19 genomes
belonging to Bacteroidetes, Clostridia, and some Actinobacteria;
and (4) the absence of galactose kinase, which was observed in
7 genomes of Firmicutes. Other problems have been observed in
1–6 analyzed genomes.
These unresolved problems can be explained by three
non-exclusive hypotheses: (1) the incompleteness of genome
sequences, (2) non-orthologous replacements for enzymes and
transporters, and (3) the existence of alternative reactions and
pathways. A total of 326 (82%) of the analyzed genomes have
draft status, and some genes for the transport and utilization of
monosaccharides may thus be absent from the current version
of the genome. Indeed, 77 genomes with absent genes have
draft status. Therefore, obtaining the finished genomes for the
studied organisms will help us to fill the gaps in the incomplete
pathways.
The problem of pathway incompleteness is only partially
resolved by the finished versions of the analyzed genomes because
incomplete pathways were also found in 13 finished genomes.
For example, the finished genome of Clostridium difficile NAP07
lacks genes for Gal- and GalNAc-specific transporters, as well
as for galactose kinase. These gaps may be filled by prediction
or experimental identification of non-orthologous replacements,
namely, genes that are not orthologs of the previously known
genes but have the same functions. Such replacements have
been previously described for the analyzed monosaccharide-
utilization pathways. Thus, pairs of non-orthologs proteins were
known for galactosamine-6-phosphate isomerase (AgaS and
AgaI), glucosamine-6-phosphate deaminase (NagB1 andNagB2),
and N-acetylglucosamine kinase (NagK1 and NagK2). Moreover,
in this study, we predicted 4 non-orthologous replacements for
enzymes (FclA2, FclD2, FclE2, and GalY) and 4 non-orthologous
replacements for transporters (FucABC, FucP2, GalP3, and
NgcABCD). The idea of non-orthologous replacement is very
promising because these replacements can be found with
computational methods alone.
Another possible way to resolve problems with incomplete
pathways is the prediction of alternative reactions or pathways.
Unlike the case of non-orthologous displacements, here, we
should predict genes with previously unknown functions, but
involved into metabolism of analyzed compounds. For example,
catabolism of Fuc, Neu5Ac, and Gal is possible via two
different pathways for each of these compounds (Figure 1B).
The prediction of novel reactions in pathways is usually more
difficult than the detection of non-orthologous displacements but
is also possible using only computational methods. For example,
an alternative pathway for the biosynthesis of menaquinone was
discovered using comparative genomics techniques (Hiratsuka
et al., 2008), and gaps in this pathway have subsequently
been filled by computational analysis (Ravcheev and Thiele,
2016).
Taken together, all the remaining problems may be resolved
using comparative genomics-based analysis. The availability of an
increasing number of microbial genomes as well as completion of
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existing genome sequences will provide significant opportunities
for the computational analyses of these microbes and the
resolution of the described problems.
Concluding Remarks and Future Plans
This study included a comprehensive computational analysis of
the degradation of mucin glycans by HGM microorganisms. In
addition to novel functional annotations, which are standard
for comparative genomics studies, this analysis also predicted
commensal interactions between different microbes, specificity
of the HGM strains to various types of glycans, and mutualistic
inter-strain interactions at the level of mucin glycan degradation.
These results demonstrate the efficiency of the selected approach:
the analysis of individual genomes for members of the microbial
community.
Although this study significantly improved our understanding
of the HGM and its interactions with the host, there is still
much to be discovered in this field. The areas lacking evidence
indicate the future directions for the analysis of the HGM as
it relates to mucin glycan degradation. The first two future
directions, which are defined by unresolved problems (see
Unresolved Problems and Possible Solutions), are to update
the metabolic reconstructions with full versions of all analyzed
genomes and to fill in the remaining gaps in the studied
metabolic pathways. The third future direction is to expand
the reconstructed metabolic, transport, and possible feeding
pathways to novel genomes; this is aimed at the growing
number of microbial genomes, including members of the HGM
community. Mucin glycans are not the only glycans that can be
degraded by HGM organisms. Thus, the fourth future direction
is pathway reconstruction for the degradation of dietary-derived
glycans.
TheHGMhas been intensively studied in relation to its impact
on human health, and more than 50 human diseases have been
shown to be associated with HGM alterations (Potgieter et al.,
2015). Nonetheless, the use of HGM taxonomical composition
as a diagnostic tool is currently hampered by the high variability
of the HGM depending on various factors (Kurokawa et al.,
2007; Clemente et al., 2012; Yatsunenko et al., 2012; Suzuki
and Worobey, 2014; Allais et al., 2015) and by functional
redundancy of the HGM. As it relates to the HGM, functional
redundancy is defined as the ability of multiple bacteria, both
closely and distantly related to each other, to implement the
same metabolic functions (Moya and Ferrer, 2016). On the
other hand, more than a dozen HGM-produced metabolites
are associated with various human diseases (Potgieter et al.,
2015), indicating possible associations between human health
and the presence or absence of certain metabolic pathways in
the HGM. Therefore, functional redundancy may provide a
possible approach for the use of the HGM to distinguish health
states of an individual. Indeed, a comparison of metagenomics
data from healthy or diseased subjects may highlight HGM
genes that are associated with disease. Because accurate
functional annotation of all the genes in each metagenome
is extremely time-consuming and costly, it makes sense to
compare different microbiomes for the presence or absence of
particular metabolic pathways that are already annotated and
possibly associated with a health state. Because the state of
the intestinal mucus layer is closely associated with human
health (Png et al., 2010; Johansson et al., 2013; Cockburn and
Koropatkin, 2016; Desai et al., 2016), HGM genes involved
in the degradation of mucin glycans are perfect candidates
to be tested for associations with health and disease. Thus,
the fifth future direction is an analysis of the presence or
absence of the analyzed genes in health and disease HGM
metagenomes.
Computational modeling of metabolism (Palsson, 2006; Orth
et al., 2010) may be used for elucidation of mucin glycan
degradation by HGM organisms. Previously, genome-based
models have been published for single representatives of the
HGM (Thiele et al., 2005, 2011, 2012; Orth et al., 2011; Heinken
et al., 2014) as well as for whole HGM communities (Levy
and Borenstein, 2013; Bauer et al., 2015; Heinken and Thiele,
2015; Noecker et al., 2016; Shashkova et al., 2016; Magnúsdóttir
et al., 2017). Additionally, computational models for human
metabolism are also available (Thiele et al., 2013b; Mardinoglu
et al., 2014), and host-microbial metabolic interactions have
been modeled (Heinken et al., 2013, 2016; Thiele et al., 2013a;
Shoaie and Nielsen, 2014; Levy et al., 2015). Thus, the final
future direction is to update the existing HGM and host-HGM
metabolic models of reactions for all the pathways reconstructed
in this study. Such an update would improve the existing models
and would improve our understanding of the interaction between
humans and their microbiome.
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